Anti-Respiratory

Respiratory disease is a common disease, frequently-occurring disease, the main lesion in the trachea, bronchi, lung and chest, lesions are more cough, chest pain, respiratory effects, severe breathing difficulties, hypoxia, and even respiratory failure and death. Due to air pollution, smoking and other factors, The chronic obstructive pulmonary disease is increasing including chronic bronchitis, emphysema, pulmonary heart disease, bronchial asthma, lung cancer, pulmonary diffuse interstitial fibrosis, and pulmonary infection the morbidity and mortality of the disease at home and abroad . Therefore, anti-respiratory disease drugs are also more and more attention paid by researchers. Respiratory disease have the symptoms of cough, sputum, hemoptysis, chest pain, shortness of breath and other symptoms of lack of specificity, often clinicians mistaken by people for colds, bronchitis, and severe pneumonia, tuberculosis or lung cancer and other diseases delayed diagnosis; Respiratory tract infection, to be developed to emphysema, pulmonary heart disease, respiratory failure was taken seriously, but it was too late, its pathology and physiological function has been difficult to reverse. As with other systemic diseases, careful and detailed medical history and physical examination are the basis for the diagnosis of respiratory diseases, and should be combined with routine laboratory tests and other special findings to conduct a comprehensive and comprehensive analysis. Currently the most clinical application of anti-respiratory disease drugs have the following four categories: 1. Antihistamines 2. Cough medicine 3. Bronchodilator 4. Expectorant 5. Anti-asthma drugs.


CAS 2338-18-3, 2-Aminoindan hydrochloride For Making Indacaterol
CAS 2338-18-3, 2-Aminoindan hydrochloride For Making Indacaterol
CAS 312753-53-0/ 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride Used for Indacaterol
CAS 312753-53-0/ 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride Used for Indacaterol
312753-53-0, Indacaterol Intermediate
312753-53-0, Indacaterol Intermediate
100331-89-3, Indacaterol Intermediate
100331-89-3, Indacaterol Intermediate
Indacaterol Intermediate CAS 100331-89-3
Indacaterol Intermediate CAS 100331-89-3
CAS 114214-69-6,3-Hydroxymethyl-pyrrolidine-1-carboxylic acid^tert-butyl ester
CAS 114214-69-6,3-Hydroxymethyl-pyrrolidine-1-carboxylic acid^tert-butyl ester
CAS 503070-57-3, Vilanterol Intermediates Benzene,2-[[2-[(6-broMohexyl)oxy]ethoxy]Methyl]-1,3-dichloro
CAS 503070-57-3, Vilanterol Intermediates Benzene,2-[[2-[(6-broMohexyl)oxy]ethoxy]Methyl]-1,3-dichloro
CAS 62932-94-9,Vilanterol Intermediate 2-Bromo-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone
CAS 62932-94-9,Vilanterol Intermediate 2-Bromo-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone
CAS 452339-73-0,Vilanterol Intermediates (5R)-2-Oxazolidinone,5-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl
CAS 452339-73-0,Vilanterol Intermediates (5R)-2-Oxazolidinone,5-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl
CAS 10447-39-9,(3-QUINUCLIDINYL)DIPHENYL CARBINOL HYDROCHLORIDE Used for Umeclidinium Bromide
CAS 10447-39-9,(3-QUINUCLIDINYL)DIPHENYL CARBINOL HYDROCHLORIDE Used for Umeclidinium Bromide
CAS 6238-33-1,Ethyl 3-quinuclidinecarboxylate Used for Umeclidinium Bromide
CAS 6238-33-1,Ethyl 3-quinuclidinecarboxylate Used for Umeclidinium Bromide
CAS 22766-68-3,1-Azabicyclo[2.2.2]octane-4-carboxylic acid, ethyl ester For Umeclidinium Bromide
CAS 22766-68-3,1-Azabicyclo[2.2.2]octane-4-carboxylic acid, ethyl ester For Umeclidinium Bromide
CAS 461648-39-5,Umeclidinium Bromide Intermediates 1-Azabicyclo[2.2.2]oct-4-yl(diphenyl)methanol
CAS 461648-39-5,Umeclidinium Bromide Intermediates 1-Azabicyclo[2.2.2]oct-4-yl(diphenyl)methanol
CAS 1462-37-9,Benzyl 2-bromoethyl ether[Intermediate of Umeclidinium Bromide]
CAS 1462-37-9,Benzyl 2-bromoethyl ether[Intermediate of Umeclidinium Bromide]
503068-34-6​ Vilanterol Base
503068-34-6​ Vilanterol Base
1462-37-9, Umeclidinium Bromide Intermediates
1462-37-9, Umeclidinium Bromide Intermediates
22766-67-2, Umeclidinium Bromide Intermediates Ethyl quinuclidine-4-carboxylate hydrochloride
22766-67-2, Umeclidinium Bromide Intermediates Ethyl quinuclidine-4-carboxylate hydrochloride
85309-91-7, 2-[(2,6-Dichlorobenzyl)oxy]ethanol For Vilanterol
85309-91-7, 2-[(2,6-Dichlorobenzyl)oxy]ethanol For Vilanterol
High Quality Umeclidinium Bromide Intermediate 22766-68-3
High Quality Umeclidinium Bromide Intermediate 22766-68-3
High Purity Vilanterol Intermediate CAS 503070-58-4
High Purity Vilanterol Intermediate CAS 503070-58-4
Pharmaceutical Grade Vilanterol Trifenatate CAS 503070-58-4
Pharmaceutical Grade Vilanterol Trifenatate CAS 503070-58-4
High Purity Intermediate of Salmeterol1-[4-[(6-Bromohexyl)oxy]butyl]benzene(94749-73-2)
High Purity Intermediate of Salmeterol1-[4-[(6-Bromohexyl)oxy]butyl]benzene(94749-73-2)
6-N-Benzylamino-1-(4'-phenylbutoxy)Hexane CAS Number 97664-55-6
6-N-Benzylamino-1-(4'-phenylbutoxy)Hexane CAS Number 97664-55-6
1156491-10-9,(1R trans)-2-(3,4-difluorophenyl)cyclopropane Amine For Tecagrelor
1156491-10-9,(1R trans)-2-(3,4-difluorophenyl)cyclopropane Amine For Tecagrelor

© 2019 CHINA WAY. All Rights Reserved.  Taizhou Volsen Chemical Co., Ltd.,  Inc.   All rights reserved. site map.  sitemap.html